MiMedx Group, Inc. (MDXG)
4.57
-0.03
(-0.65%)
USD |
NASDAQ |
Sep 11, 16:00
4.565
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price : 4.57 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.64 | 4.71 | 4.51 | 4.57 | 995845.0 |
| Sep 10, 2026 | 4.65 | 4.69 | 4.50 | 4.60 | 1.622M |
| Sep 09, 2026 | 4.64 | 4.70 | 4.56 | 4.68 | 1.049M |
| Sep 08, 2026 | 4.57 | 4.73 | 4.43 | 4.67 | 1.065M |
| Sep 04, 2026 | 4.41 | 4.585 | 4.41 | 4.57 | 624972.0 |
| Sep 03, 2026 | 4.54 | 4.61 | 4.345 | 4.43 | 841628.0 |
| Sep 02, 2026 | 4.52 | 4.71 | 4.52 | 4.55 | 1.040M |
| Sep 01, 2026 | 4.53 | 4.61 | 4.485 | 4.52 | 762366.0 |
| Aug 31, 2026 | 4.49 | 4.57 | 4.395 | 4.54 | 1.063M |
| Aug 28, 2026 | 4.49 | 4.635 | 4.48 | 4.50 | 887017.0 |
| Aug 27, 2026 | 4.45 | 4.76 | 4.45 | 4.51 | 1.179M |
| Aug 26, 2026 | 4.33 | 4.44 | 4.27 | 4.42 | 711026.0 |
| Aug 25, 2026 | 4.28 | 4.38 | 4.27 | 4.34 | 700021.0 |
| Aug 24, 2026 | 4.36 | 4.39 | 4.24 | 4.27 | 846657.0 |
| Aug 21, 2026 | 4.30 | 4.35 | 4.25 | 4.33 | 897111.0 |
| Aug 20, 2026 | 4.40 | 4.47 | 4.28 | 4.30 | 1.433M |
| Aug 19, 2026 | 4.37 | 4.50 | 4.365 | 4.45 | 1.160M |
| Aug 18, 2026 | 4.20 | 4.37 | 4.20 | 4.34 | 1.220M |
| Aug 17, 2026 | 4.26 | 4.28 | 4.175 | 4.19 | 898512.0 |
| Aug 14, 2026 | 4.19 | 4.315 | 4.12 | 4.27 | 974771.0 |
| Aug 13, 2026 | 4.28 | 4.31 | 4.165 | 4.20 | 1.068M |
| Aug 12, 2026 | 4.32 | 4.375 | 4.265 | 4.28 | 729380.0 |
| Aug 11, 2026 | 4.29 | 4.36 | 4.265 | 4.32 | 1.229M |
| Aug 10, 2026 | 4.31 | 4.39 | 4.215 | 4.27 | 1.156M |
| Aug 07, 2026 | 4.19 | 4.385 | 4.14 | 4.34 | 1.362M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 20.86 |
| Perspective Therapeutics, Inc. | 2.81 |
| ABVC BioPharma, Inc. | 0.9801 |
| Enovis Corp. | 19.28 |
| Edwards Lifesciences Corp. | 84.37 |
Price Related Metrics
| PE Ratio | 115.70 |
| PS Ratio | 1.918 |
| Price to Book Value | 3.083 |
| Price to Free Cash Flow | 16.09 |
| Earnings Yield | 0.86% |
| Market Cap | 665.96M |
| Operating PE Ratio | 77.82 |
| Normalized PE Ratio | 115.99 |